Sarepta Therapeutics Inc (NASDAQ:SRPT)

Tuesday’s Trading Day
13.28 -0.59 / -4.25%
As of Mar 31
Day’s Change
Wednesday’s Pre-Market   Switch to standard view »
13.26 -0.02 / -0.15%
Volume: 200.00
Health Technology

Company Description

Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Contact Information

Sarepta Therapeutics, Inc.
215 First Street
Cambridge Massachusetts 02142
P:(857) 242-3700
Investor Relations:
(857) 242-3714



Mutual fund holders34.78%
Other institutional26.59%
Individual stakeholders0.50%

Top Executives

Christopher Nishan GarabedianPresident, Chief Executive Officer & Director
Sandesh MahatmeSenior VP, Chief Financial & Accounting Officer
Patrick L. IversenSenior Vice President-Research & Innovation
Edward M. KayeChief Medical Officer & Senior Vice President
David Tyronne HowtonSecretary, Senior Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account